GREENBURGH, N.Y. -- An Elmsford pharmacy management company, BioScrip, will pay $15 million in a settlement after claims it wrote excessive prescriptions in return for kickbacks from the pharmaceutical giant Novartis, according to LoHud.com.
An Elmsford pharmacy management company is paying a $15 million settlement.
Photo Credit: Flickr user AKZOphotoThe settlement reportedly claims that BioScrip pushed the iron-reducing medication Exjade, despite doctors' concerns about harmful side effects.
Click here to read the full LoHud.com report.
Click here to follow Daily Voice Greenburgh and receive free news updates.
50°